The companies will provide assays for functional comparability, for use in quality control, lot release, and stability testing of biosimilars and biobetters.

Researchers at the University of Pittsburgh say the compound may be more potent and selective than drugs currently available to treat epilepsy.

Schreiner MediPharm will introduce Flexi-Cap Protect, a label-and-cap combination with additional protection features, to the US market at INTERPHEX 2016.

Marchesini Group’s Extrafill, a filling and stoppering machine, contains a robotic arm gripper system designed to move like a human hand.

Steriline’s enhanced robotic aseptic vial filler and capper line includes RA-V4 Rotary Vial Washing Machine, a depyrogenation tunnel, the RVFCM50 Robotic Vial Filling and Capping Machine with Isolator, and an EDM-C External Decontaminating Machine.

The Planeta 200 Capsule Filler’s modular design can be configured for a variety of production requirements.

AdvantaPure’s BioClosure container closures are intended to save time and money on inventoried parts, assembly, and cleaning validations.

Optima introduces OPTIMA H4 and the Multiuse series for multiple filling operations.

The new research scheme will be based in GE’s Turkey-based innovation center, and will help support the region’s biopharmaceutical industry.

The commercial partnership aims to use digital health tools including sensors, apps, analytics, personal feedback, and education to assist patients in monitoring respiratory diseases.

Cinqair is approved for patients that have a history of severe asthma attacks despite receiving their current asthma medication.

The drug is marketed by Eli Lilly in the US, and will be available at the beginning of the second quarter of 2016.

The report examines the increased number of companies cited by regulators for data integrity issues.

Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.

A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.

A new 3D modeling and data-extraction technique Improves X-ray crystallography analysis of proteins.

The Matrix Alliance was formed by Vanrx Pharmasystems with inaugural members ARaymond Life, Daikyo Seiko, Datwyler Group, Ompi, Schott AG, Schott Kaisha and SiO2 Medical Products.

The draft guidance outlines ways applicants can test for abuse deterrence in solid oral opioid drugs.

Collaboration will provide for unified development and manufacture of antibody drug conjugates.

The taskforce will work to identify opportunities to advance therapy manufacturing and the supply chain in the UK.

The company broke ground on a $79 million production facility at its Ravensburg Schuetzenstrasse site.

The BARDA-supported monoclonal antibody was approved both as a treatment after anthrax exposure and as an anthrax prophylactic.

The partnership aims to facilitate the development of therapeutic and diagnostic candidates for European biopharmaceutical clients.

Generic drugs, market access, and foreign manufacturing are conference topics at CPhI Japan 2016.

The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.

The conference discussed key industry issues including serialization, innovation, and patient-centricity.

The agency announced enhanced warnings for immediate-release opioids to inform prescribers and patients of risks related to use.

Hospira recalls one lot of 8.4% Sodium Bicarbonate Injection, USP, due to particulate matter found within a single-dose glass fliptop vial.